Impel Pharmaceuticals Inc. news

• Patient Access to Trudhesa® to Continue Uninterrupted
• Sufficient Liquidity to Fund Day to Day Operations During Court-Supervised Process

Impel Pharmaceuticals Inc. (OTCQX: IMPL) ("Impel" or "the Company"), a commercial-stage biopharmaceutical company with a mission to develop transformative therapies for people suffering from diseases with high unmet medical needs, today announced that it is pursuing a sale of the Company and has entered into an agree